Old Web
English
Sign In
Acemap
>
authorDetail
>
Damaris Meyn
Damaris Meyn
Medicine
Clinical pharmacy
Emergency medicine
Psychological intervention
Intensive care unit
4
Papers
12
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
The janus-kinase inhibitor ruxolitinib in SARS-CoV-2 induced acute respiratory distress syndrome (ARDS).
2021
Leukemia
Andreas Neubauer
Johannes Johow
Elisabeth Mack
Andreas Burchert
Damaris Meyn
Andrea Kadlubiec
Iuliu Torje
Hinnerk Wulf
Claus Vogelmeier
Joachim Hoyer
Chrysanthi Skevaki
Ralf Michael Muellenbach
Christian Keller
Carmen Schade-Brittinger
Caroline Rolfes
T. Wiesmann
Show All
Source
Cite
Save
Citations (2)
Publisher Correction: The janus-kinase inhibitor ruxolitinib in SARS-CoV-2 induced acute respiratory distress syndrome (ARDS).
2021
Leukemia
Andreas Neubauer
Johannes Johow
Elisabeth Mack
Andreas Burchert
Damaris Meyn
Andrea Kadlubiec
Iuliu Torje
Hinnerk Wulf
Claus Vogelmeier
Joachim Hoyer
Chrysanthi Skevaki
Ralf Michael Muellenbach
Christian Keller
Carmen Schade-Brittinger
Caroline Rolfes
T. Wiesmann
Show All
Source
Cite
Save
Citations (0)
Clinically Relevant Interactions with Anti-Infectives on Intensive Care Units—A Multicenter Delphi Study
2021
Antibiotics
Joachim Andreas Koeck
Heike Hilgarth
Andreas von Ameln-Mayerhofer
Damaris Meyn
Ruediger Warlich
Andreas Münstedt
Dagmar Horn
Christina König
Show All
Source
Cite
Save
Citations (0)
A new approach on assessing clinical pharmacists’ impact on prescribing errors in a surgical intensive care unit
2019
International Journal of Clinical Pharmacy
Nora Kessemeier
Damaris Meyn
Michael Hoeckel
Joerg Reitze
Carsten Culmsee
Michael Tryba
Show All
Source
Cite
Save
Citations (10)
1
map